Fradelizi D - Search Results

1

CD82, tetra-span-transmembrane protein, is a regulated transducing molecule on U937 monocytic cell line.

Lebel-Binay S, Lagaudrière C, Fradelizi D, Conjeaud H. Lebel-Binay S, et al. Among authors: fradelizi d. J Leukoc Biol. 1995 Jun;57(6):956-63. doi: 10.1002/jlb.57.6.956. J Leukoc Biol. 1995. PMID: 7790779

2

Further characterization of CD82/IA4 antigen (type III surface protein): an activation/differentiation marker of mononuclear cells.

Lebel-Binay S, Gil ML, Lagaudriere C, Miloux B, Marchiol-Fournigault C, Quillet-Mary A, Lopez M, Fradelizi D, Conjeaud H. Lebel-Binay S, et al. Among authors: fradelizi d. Cell Immunol. 1994 Apr 1;154(1):468-83. doi: 10.1006/cimm.1994.1092. Cell Immunol. 1994. PMID: 7510585

3

CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T cell activation.

Lebel-Binay S, Lagaudrière C, Fradelizi D, Conjeaud H. Lebel-Binay S, et al. Among authors: fradelizi d. J Immunol. 1995 Jul 1;155(1):101-10. J Immunol. 1995. PMID: 7602090

4

The tetraspanin protein CD82 associates with both free HLA class I heavy chain and heterodimeric beta 2-microglobulin complexes.

Lagaudrière-Gesbert C, Lebel-Binay S, Wiertz E, Ploegh HL, Fradelizi D, Conjeaud H. Lagaudrière-Gesbert C, et al. Among authors: fradelizi d. J Immunol. 1997 Mar 15;158(6):2790-7. J Immunol. 1997. PMID: 9058814

5

Signaling through the tetraspanin CD82 triggers its association with the cytoskeleton leading to sustained morphological changes and T cell activation.

Lagaudrière-Gesbert C, Lebel-Binay S, Hubeau C, Fradelizi D, Conjeaud H. Lagaudrière-Gesbert C, et al. Among authors: fradelizi d. Eur J Immunol. 1998 Dec;28(12):4332-44. doi: 10.1002/(SICI)1521-4141(199812)28:12<4332::AID-IMMU4332>3.0.CO;2-8. Eur J Immunol. 1998. PMID: 9862370 Free article.

6

Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin-13.

Lebel-Binay S, Laguerre B, Quintin-Colonna F, Conjeaud H, Magazin M, Miloux B, Pecceu F, Caput D, Ferrara P, Fradelizi D. Lebel-Binay S, et al. Among authors: fradelizi d. Eur J Immunol. 1995 Aug;25(8):2340-8. doi: 10.1002/eji.1830250833. Eur J Immunol. 1995. PMID: 7664796

7

In vitro differentiation of peripheral blood T cells towards a type 2 phenotype is impaired in rheumatoid arthritis (RA).

Asselin S, Conjeaud H, Fradelizi D, Breban M. Asselin S, et al. Among authors: fradelizi d. Clin Exp Immunol. 1998 Nov;114(2):284-92. doi: 10.1046/j.1365-2249.1998.00709.x. Clin Exp Immunol. 1998. PMID: 9822289 Free PMC article.

8

Stable polarization of peripheral blood T cells towards type 1 or type 2 phenotype after polyclonal activation.

Asselin S, Conjeaud H, Minty A, Fradelizi D, Breban M. Asselin S, et al. Among authors: fradelizi d. Eur J Immunol. 1998 Feb;28(2):532-9. doi: 10.1002/(SICI)1521-4141(199802)28:02<532::AID-IMMU532>3.0.CO;2-U. Eur J Immunol. 1998. PMID: 9521063 Free article.

9

Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets.

Quillet-Mary A, Cavarec L, Kermarrec N, Marchiol-Fournigault C, Gil ML, Conjeaud H, Fradelizi D. Quillet-Mary A, et al. Among authors: fradelizi d. Int J Cancer. 1991 Feb 1;47(3):473-9. doi: 10.1002/ijc.2910470328. Int J Cancer. 1991. PMID: 1704356

10

An improved double fluorescence flow cytometry method for the quantification of killer cell/target cell conjugate formation.

Cavarec L, Quillet-Mary A, Fradelizi D, Conjeaud H. Cavarec L, et al. Among authors: fradelizi d. J Immunol Methods. 1990 Jul 3;130(2):251-61. doi: 10.1016/0022-1759(90)90055-z. J Immunol Methods. 1990. PMID: 2197333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters